REQUEST A DEMO
Total
USD $0.00
Search more companies

Alvogen (Thailand) Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Alvogen (Thailand) Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Alvogen (Thailand) Limited is a company based in Thailand, with its head office in Bangkok , Special Governed District of. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on May 14, 2026. 100 (estimated) employees currently work for Alvogen (Thailand) Limited. In 2024, the company reported a net sales revenue increase of 100.04%. Over the same period, its total assets grew by 726.91%.

Headquarters
689 Sukhumvit Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10110

Contact Details: Purchase the Alvogen (Thailand) Limited report to view the information.

Basic Information
Total Employees:
Purchase the Alvogen (Thailand) Limited report to view the information.
Financial Auditors:
Purchase the Alvogen (Thailand) Limited report to view the information.
Incorporation Date:
May 14, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Alvogen (Thailand) Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
100.04%
Total Operating Revenue
99.67%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
726.91%
Total Equity
56.13%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
948.38%
Quick Ratio
38.86%
Cash Ratio
35.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?